PET PET
  • My Account
  • Subscribe
Become a Friend Donate
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • About Us
    • People
    • Press Office
    • Our History
  • Get Involved
    • Become a Friend of PET
    • Volunteer
    • Campaigns
    • Writing Scheme
    • Partnership and Sponsorship
    • Advertise with Us
  • Donate
    • Become a Friend of PET
  • BioNews
    • News
    • Comment
    • Reviews
    • Elsewhere
    • Topics
    • Glossary
    • Newsletters
  • Events
    • Upcoming Events
    • Previous Events
  • Engagement
    • Policy and Projects
      • Resources
    • Education
  • Jobs & Opportunities
  • Contact Us
  • My Account
  • Subscribe
  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements
PETBioNewsReviewsEvent Review: The Ethics of Mitochondrial Replacement Therapy

BioNews

Event Review: The Ethics of Mitochondrial Replacement Therapy

Published 21 July 2014 posted in Reviews and appears in BioNews 763

Authors

Professor Vardit Ravitsky

Dr John Appleby

Lecturer in medical ethics, Lancaster University

Professor Stephen Wilkinson

Dr Anthony Wrigley

Dr Annelien Bredenoord

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).

Ethical dimensions of the emerging technology of mitochondrial replacement were the focus of a symposium that took place on 25 June at the 12th World Congress of Bioethics in Mexico City....


The Ethics of Mitochondrial Replacement Therapy

Organised by the World Congress of Bioethics

Don Alberto 2, Hilton Mexico City Reforma, 70 Colonia Centro, Federal District, Mexico City 06010, Mexico

Wednesday 25 June 2014

'The Ethics of Mitochondrial Replacement Therapy', organised by the World Congress of Bioethics, Wednesday 25 June 2014


Ethical dimensions of the emerging technology of mitochondrial replacement were the focus of a symposium that took place on 25 June at the 12th World Congress of Bioethics in Mexico City.

Mitochondrial DNA (mtDNA) disorders are among the most commonly inherited neuromuscular diseases and can cause immense suffering and death. The development of new technologies may lead to the replacement of mitochondria carrying harmful mtDNA mutations with 'healthy' mitochondria from donated eggs. These experimental techniques may allow parents who are likely to pass on mtDNA disorders to have a genetically related child without the disorder. However, they raise challenging ethical issues.

Dr Annelien Bredenoord discussed the ethical challenges raised by the uncertainty of first using such radical new techniques. She highlighted the fact that the techniques modify the germline and modifications would thus be transmitted to subsequent generations. This raises the challenge of evaluating intergenerational risks and benefits. She also discussed the ethics of using nonhuman primates and embryos in preclinical research to reduce risks.

Dr Bredenoord argued that to be justifiable, mitochondrial replacement should present a favourable balance of risks and benefits in comparison with current alternatives, namely egg donation, prenatal diagnosis and preimplantation genetic diagnosis. She suggested that the most challenging ethical issue is justifying the leap from 'bench to bedside' in the presence of promising preclinical results. In many other risky first-in-human studies the research participant decides whether to take the risk, but in this case the couple decides and the prospective child carries the risk. It is thus of tremendous importance to rigorously evaluate preclinical safety data and to ensure long term follow up in order to enhance the ethical acceptability of mitochondrial replacement as a reproductive option.

Dr John Appleby considered the anonymity of mitochondrial donors in light of recent proposed legislation by the UK Department of Health to make mitochondrial donation anonymous, even though anonymous gamete donation is prohibited. This discrepancy appears to be based on the view that mitochondrial donation is unlikely to affect the identity of offspring and that future persons are thus unlikely to want to know who their donors were.

The mitochondrial genome is much smaller than the nuclear genome and so is thought not to have the same phenotypic effects on a future person as a nuclear genome. However, Dr Appleby argued that donor conceived persons do not typically understand their identities in a narrow genetic sense and often have other reasons for wanting to know the identity of their donors. He concluded that until we have strong grounds for doing otherwise, it would be unjustified to treat mitochondrial donors differently from other gamete donors and that neither should be anonymous.

Dr Anthony Wrigley outlined ways in which our genetic origins might play a role in determining our identity in light of mitochondrial replacement techniques. Currently, two techniques are suggested: 'maternal spindle transfer' (MST) in which mitochondrial transfer occurs before fertilisation and 'pronuclear transfer' (PNT) in which it occurs after the egg has been fertilised, and therefore after the core genetic identity of the future person has been established.

Dr Wrigley explored how Parfit's Non-Identity Problem can be applied to inform our ethical evaluation of these two techniques by asking: 'does using technique x cause a (numerically) different individual to be born than if technique x were not used?'. He argued that this would be true for MST, since the genetic identity of the future individual is created after the intervention and in this sense the intervention creates a different individual. However, it would not be true for PNT, since the genetic identity is created prior to the intervention. Therefore, in cases of MST, we cannot normally claim that individuals so created have been harmed or have benefitted from mitochondrial replacement. However, cases of PNT can be seen as modifying an existing individual and could therefore be classified as 'treatment'.

Professor Stephen Wilkinson built on this conclusion that MST is a form of selective reproduction (selecting individual x rather than y) whereas PNT is a case of embryo modification, and discussed the ethical implications of such a distinction. He argued that straightforward attributions of harm and benefit could be harder in the case of MST because of the Non-Identity Problem.

Moreover, he emphasised that concerns about eugenics and human dignity, which some critics have raised, could be stronger in the case of MST if this involves 'selecting out' embryos with mitochondrial disease (whereas PNT involves attempting to 'treat' them). Finally, he argued that parents' obligations to seek treatment could be stronger in the case of PNT, because not doing so may harm their future child and may be compared to (or even be an instance of) failing to provide needed medical treatment. This however would not apply to MST, if MST is 'selection' rather than modification or treatment.

Finally, Professor Vardit Ravitsky highlighted the extensive media coverage of the public debate surrounding this controversial technology and discussed the role the media plays in shaping public perceptions. She presented various portrayals of mitochondrial replacement in the media and offered some reflections regarding how different framings may shape the public debate. She analysed the implications of using sensationalist terminology such as 'three-parent babies' and 'genetically modified children' versus more neutral and scientific terminology such as 'transfer' or 'replacement' and even favourable terminology such as 'therapy' and 'life-saving treatment'. She argued that as experts, bioethicists and scientists have a responsibility to carefully choose terminology and framing when informing the media and the public.

The symposium was part of a five-year programme of
research titled 'The Donation and Transfer of Human Reproductive Materials', led
jointly by Rosamund Scott (Professor of Medical Law and Ethics at King's
College, London) and Stephen Wilkinson (Professor of Bioethics at Lancaster
University). It is funded by a Wellcome Trust Senior Investigator Award in
Ethics and Society and runs from 2013 until 2017. To find out more about the
project please click here.

Related Articles

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
Reviews
23 March 2015 • 4 minutes read

Event Review: In conversation with Dr Amy Gutmann

by Dr Rachel Montgomery

On 15 March 2015, the Nuffield Council on Bioethics held its annual public lecture, which this year featured political scientist and philosopher Dr Amy Gutmann, chair of the US Presidential Commission for the Study of Bioethical Issues...

Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family (from Greek and Roman mythology) entwined in coils of DNA.
Image by Bill Sanderson via the Wellcome Collection, © Wellcome Trust Ltd 1990. Depicts Laocoön and his family entwined in coils of DNA (based on the figure of Laocoön from Greek and Roman mythology).
Reviews
17 November 2014 • 4 minutes read

Event Review: Bioethics in 2025 - What Will Be the Challenges?

by Dr Louisa Petchey

This Nuffield Council debate was instead a surprisingly thoughtful discussion on what bioethicists are doing now, on what we could do, the speakers asked whether we are moving closer to or further away from a future we are happy with...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
6 June 2014 • 4 minutes read

Mitochondrial replacement likely to be safe but more research needed, says report

by Alice Plein

Two experimental IVF techniques that could prevent certain types of incurable genetic disease are 'not unsafe', a report from the UK's Human Fertilisation and Embryology Authority has found....

Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the output from a DNA sequencing machine.
CC BY 4.0
Image by Peter Artymiuk via the Wellcome Collection. Depicts the shadow of a DNA double helix, on a background that shows the fluorescent banding of the sequencing output from an automated DNA sequencing machine.
Comment
21 March 2014 • 3 minutes read

Is mitochondrial donation 'genetic engineering'?

by Professor Janna Thompson

MP Jacob Rees-Mogg recently implied that mitochondrial transfer is akin to eugenics, but it is a way of combating debilitating ailments rather than producing 'perfect' human beings...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
17 March 2014 • 2 minutes read

Conservative MP says mitochondrial donation will produce 'genetically modified children'

by Dr Louisa Petchey

The Conservative MP for North East Somerset, Jacob Rees-Mogg, has said that mitochondrial donation will produce 'genetically modified children' with 'three parents', and was 'effectively cloning'...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 February 2014 • 2 minutes read

Draft regulations on mitochondrial donation published

by Patricia Cassidy

The UK Department of Health has published draft guidelines for the use of new techniques to prevent mothers passing on serious mitochondrial diseases to their children. The guidelines will be the subject of a three-month consultation...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
News
28 February 2014 • 2 minutes read

FDA Advisory Committee weighs up mitochondrial replacement

by Chee Hoe Low

The USA's Food and Drug Administration (FDA) is considering whether to allow human clinical trials of mitochondrial replacement, an IVF technique that uses gametes from three people...

Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
CC0 1.0
Image by Alan Handyside via the Wellcome Collection. Depicts a human egg soon after fertilisation, with the two parental pronuclei clearly visible.
Comment
24 February 2014 • 4 minutes read

Mitochondrial transfer and three-person IVF: What's in a name?

by Dr Roger Sturmey

The description of mitochondrial transfer as 'three-person IVF' may conjure up some unnerving perceptions of the consequences, and may be met in the public arena with discomfort, but it's worth considering the fundamental aspects of this approach...

Leave a Reply Cancel reply

You must be logged in to post a comment.

« Event Review: Genomic Sequencing - Why Is It Important and How Can It Help You?

Data-Label The UK's Leading Supplier Of Medical Labels & Asset Labels

RetiringDentist.co.uk The UK's Leading M&A Company.

Find out how you can advertise here
easyfundraising
amazon

This month in BioNews

  • Popular
  • Recent
1 August 2022 • 3 minutes read

Podcast Review: Stories of Our Times – IVF, fraud and 'unwanted' children

25 July 2022 • 4 minutes read

TV Review: DNA Family Secrets – series two, episode six

18 July 2022 • 4 minutes read

TV Review: Spotlight – The babymaker uncovered

4 July 2022 • 3 minutes read

Podcast Review: Biohacked Family Secrets – The birth of the sperm bank

20 June 2022 • 5 minutes read

Documentary Review: Our Father

15 August 2022 • 3 minutes read

Radio Review: The Life Scientific – Shankar Balasubramanian on decoding DNA

8 August 2022 • 4 minutes read

Podcast Review: Babbage – Editing the code of life

1 August 2022 • 3 minutes read

Podcast Review: Stories of Our Times – IVF, fraud and 'unwanted' children

25 July 2022 • 4 minutes read

TV Review: DNA Family Secrets – series two, episode six

18 July 2022 • 4 minutes read

TV Review: Spotlight – The babymaker uncovered

Subscribe to BioNews and other PET updates for free.

Subscribe
  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856

Subscribe to BioNews and other PET updates for free.

Subscribe
PET PET

PET is an independent charity that improves choices for people affected by infertility and genetic conditions.

  • Twitter
  • Facebook
  • Instagram
  • LinkedIn
  • YouTube
  • RSS
Wellcome
Website redevelopment supported by Wellcome.

Navigation

  • About Us
  • Get Involved
  • Donate
  • BioNews
  • Events
  • Engagement
  • Jobs & Opportunities
  • Contact Us

BioNews

  • News
  • Comment
  • Reviews
  • Elsewhere
  • Topics
  • Glossary
  • Newsletters

Other

  • My Account
  • Subscribe

Website by Impact Media Impact Media

  • Privacy Statement
  • Advertising Policy
  • Thanks and Acknowledgements

© 1992 - 2022 Progress Educational Trust. All rights reserved.

Limited company registered in England and Wales no 07405980 • Registered charity no 1139856